Depression and the use of antidepressants in cardiovascular diseases from a cardiologist's perspective

Authors

  • Diana Blat Cardiology Department, Voivodeship Specialist Hospital of Lublin Author
  • Ewa Stelmach II Department of Psychiatry and Psychiatric Rehabilitation, Medical University of Lublin Author https://orcid.org/0000-0001-7866-6556

DOI:

https://doi.org/10.2478/cpp-2021-0008

Keywords:

depression, antidepressants, cardiovascular diseases, heart attack, coronary disease

Abstract

Introduction: Cardiovascular diseases, especially coronary heart disease or heart failure, are often chronic.

Aim and method: The aim of this study was to review the literature on the prevalence of depressive disorders and the use of antidepressants in cardiovascular disease. For this purpose, articles available in PubMed and Google Scholar databases were used.

Results: About one in five patients with cardiovascular disease suffers from major depressive disorder. Psychosocial stress, depression and anxiety, are associated with poorer prognosis and make it more difficult for patients to make positive lifestyle changes and comply with medical recommendations. Conversely, depressive symptoms are associated with an increased risk of cardiovascular incidents. Regarding pharmacotherapy, selective serotonin reuptake inhibitors (SSRIs) are considered safe drugs, while tricyclic antidepressants are not recommended. In the treatment of depression and cardiovascular diseases, supplementation or a diet rich in omega-3 fatty acids is worth mentioning.

Conclusions: The above literature review highlights the need for a multidirectional approach that is essential to diagnose, understand and then treat these, often comorbid, conditions of cardiovascular disease and depression.

References

1. Pędzich, Z. (ed.), Psychotherapy with dance and movement. Individual and group therapy. Sopot: Gdańskie Wydawnictwo Psychologiczne, 2014.

2. Czubała, J. C., Czynniki leczące w psychoterapii, Warszawa: Wydawnictwo Naukowe PWN, 1997.

3. Payne, H. (red.), Dance movement therapy: Theory, reasearch and practice (wyd. 2). London - New York: Routledge - Taylor & Francis Group, 1992.

4. Sachs, C., World history of the dance. New York: W. W. Norton & Co, 1965.

5. Levy, F. J., Dance/movement therapy: A headling art. Reston: National Dance Assiciacion, American Alliance for Health, Physical Education, Recreation, and Dance, 1992.

6. Payne, H., Supervision of dance movement psychotherapy: A practitioners guide, London - New York: Routledge, 2008.

7. Siegell, E. V., Psychoanalytic dance therapy: The Bridge between psyche and soma, American Journal of Dance Therapy, 17(2), 115-128, 1995.

8. Meekums, B., Dance movement therapy. A creative psychoterapeutic approach. London: Sage Publications, 2002.

9. Winnicott, D. W., Children and their mothers, Transl. M. Halaba. Warsaw: W.A.B., 1994.

10. Galecki P., Szulc A., Psychiatry, edra Urban & Partner, Wroclaw 2018: 160-161.

11. Pużyński St., Rybakowski J., Wciórka J., Psychiatria tom 2 -Psychiatria kliniczna, wyd. Elsevier Urban & Partner, Wrocław, 2011: 233-238.

12. ICD-10 Classification of Mental and Behavioural Disorders, University Medical Publishing House “Vesalius”, Krakow-Warsaw, 2000: 50-54.

13. Newlove J., Dalby J., Laban for all - Polish translation, Kined Publishers, Warsaw, 2011: 121-140.

14. Winnicott D.W., Play and reality, Imago Publishers, Gdańsk, 2011: 82-96.

15. Barbara A., Applications of Laban Movement Analysis: An Integrated Approach to Voice, Speech and Movement Training for Actors, Journal of Laban Movement Studies, New York, 2008.

16. Yalom I., Group Psychotherapy - Theory and Practice, Jagiellonian University, Krakow, 2006.

Downloads

Published

2021-09-11

How to Cite

Blat, D. ., & Stelmach, E. . (2021). Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective. Current Problems of Psychiatry, 22(2), 87-93. https://doi.org/10.2478/cpp-2021-0008